Advanced
Product
Solutions
Partners
Resources
Company
Toggle menu
Home
/
Prime Medicine
Prime Medicine
Overview
Locations
Financials
Operating Metrics
Human Capital
Key People
Competitors
Supplier Risk
Prime Medicine
Stock Price
$4.1
2024-10-29
Market Capitalization
$489.7 M
2024-10-29
Revenue
$4.6 M
FY, 2025
Prime Medicine Summary
Company Summary
Overview
Prime Medicine is a biotechnology company that develops a gene-editing technology. It uses Prime Editing technology that acts as a DNA word processor to search and replace disease-causing genetic sequences at their precise location in the genome.
Type
Public
Status
Active
Founded
2019
HQ
Cambridge, MA, US
|
view all locations
Website
https://www.primemedicine.com
Cybersecurity rating
Sectors
Technology
biotech
genetics
healthtech
medical diagnostics
Homepage
Linkedin
Table of Contents
Key People
Locations
Financials
Competitors
Key People
Keith Gottesdiener,
President and CEO, Director
Linkedin
Jeremy Duffield,
CSO
Linkedin
Ann Lee,
CTO
Linkedin
Niamh Alix,
CHRO
Linkedin
and 13 others
Locations
View all
1 location detected
Cambridge, MA
HQ
United States
21 Erie St
Prime Medicine Financials
Summary Financials
Net income (Q1, 2026)
($49.1M)
Cash (Q1, 2026)
$64.1M
EBIT (Q1, 2026)
($50.7M)
Enterprise value
$540.1M
Competitors and Similar Companies
Astellas Gene Therapies
Healthcare - Subsidiary
Human Longevity
Technology - Private
GenePlanet
Healthcare - Private
TwinStrand Biosciences
Technology - Private
Compare competitors
Footer menu
Contact us
Product
Intelligence Suite
Supplier Intelligence Platform
Craft Intelligence Portal
Craft API
Craft for Teams
Supplier Intelligence Platform
Craft Alerts
Craft N-Tier Mapping
Craft Risk Hub
Chrome extension
Solutions
Supplier Intelligence
Sales Intelligence
Aerospace and Defense
Resources
Resource center
Blog
Company
About
Careers
Contact
Terms of Service
Privacy Policy
Security
© Craft.co 2026
Share price data provided by IEX
Back
to top